Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 can cause skin problems and affect dermatology treatments, with recommendations for skin care and cautious use of certain drugs.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Current treatments for folliculitis decalvans include antibiotics, isotretinoin, and potential new therapies like botulinum toxin A and PRP.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Animal models have helped understand hair loss from alopecia areata and find new treatments.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Janus kinase inhibitors show promise in treating alopecia areata but need better topical formulations.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

The best treatment for Frontal Fibrosing Alopecia and Lichen Planopilaris combines oral and topical medications to reduce symptoms and stop hair loss.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

JAK inhibitors may help treat alopecia areata and promote hair regrowth.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Higher granulysin levels in the blood are linked to more severe hair loss in alopecia areata patients, and these levels decrease after effective treatment.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Pediatric dermatologists have varied preferences for treating alopecia areata in children, with no standard FDA-approved treatments and some using JAK inhibitors despite risks.

Baricitinib effectively regrows hair in most people with severe alopecia, especially those with patchy hair loss, but hair may fall out again if treatment stops.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.